These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3932716)

  • 1. [Studies on the usefulness of double filtration plasmapheresis in a hemophilia A patient with anti-factor VIII antibody (inhibitor)].
    Okubo S; Ikuma T; Hamaguchi Y; Yasunaga K
    Rinsho Ketsueki; 1985 May; 26(5):701-8. PubMed ID: 3932716
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of severe bleeding in hemophilia A with factor VIII inhibitor.
    Mahasandana C; Suvatte V; Tanphaichitr VS; Bejrachandra S; Chandanayingyong D
    J Med Assoc Thai; 1988 Mar; 71(3):154-8. PubMed ID: 3133440
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined plasmapheresis and immunosuppression in hemophilia in a patient with antibodies].
    Révész T; Mátyus J; Goldschmidt B; Harsányi V
    Orv Hetil; 1980 Jul; 121(29):1753-4. PubMed ID: 6779250
    [No Abstract]   [Full Text] [Related]  

  • 4. Characterization of an acquired factor VIII inhibitor and plasmapheresis therapy in a patient with bullous pemphigoid.
    Zhang GS; Zuo WL; Dai CW; Xu YX; Shen JK; Luo YY; Yi Y
    Thromb Haemost; 2006 Nov; 96(5):692-4. PubMed ID: 17080230
    [No Abstract]   [Full Text] [Related]  

  • 5. Extracorporeal protein A-sepharose and specific affinity chromatography for removal of antibodies.
    Nilsson IM; Sundqvist SB; Freiburghaus C
    Prog Clin Biol Res; 1984; 150():225-41. PubMed ID: 6431430
    [No Abstract]   [Full Text] [Related]  

  • 6. [Use of the cell-separator in the treatment of factor-VIII-inhibitor hemophilia].
    Piller G; Druml W; Höcker P; Niessner H; Rainer H; Lechner K
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 2():1654-9. PubMed ID: 1030071
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibitor antibody development and T cell response to human factor VIII in murine hemophilia A.
    Qian J; Borovok M; Bi L; Kazazian HH; Hoyer LW
    Thromb Haemost; 1999 Feb; 81(2):240-4. PubMed ID: 10063999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response induced by porcine factor VIII in severe hemophiliacs with antibody to F VIII.
    Verroust F; Allain JP
    Thromb Haemost; 1982 Oct; 48(2):238. PubMed ID: 6817447
    [No Abstract]   [Full Text] [Related]  

  • 9. Experience with factor VIII: C inhibitors and acquired von Willebrand's disease in an adult at Ramathibodi Hospital.
    Angchaisuksiri P; Atichartakarn V; Pathepchotiwong K; Jootar S; Ungkanont A; Chuncharunee S
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():152-8. PubMed ID: 7886560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII inhibitors.
    Gilles JG; Jacquemin MG; Saint-Remy JM
    Thromb Haemost; 1997 Jul; 78(1):641-6. PubMed ID: 9198231
    [No Abstract]   [Full Text] [Related]  

  • 11. Factor VIII inhibitors: a continuing problem.
    Hoyer LW
    J Lab Clin Med; 1993 Mar; 121(3):385-7. PubMed ID: 8445287
    [No Abstract]   [Full Text] [Related]  

  • 12. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of factor VIII antibody in haemophilic monozygotic twins. European Study Group of Factor VIII Antibody.
    Scand J Haematol; 1979 Jul; 23(1):64-8. PubMed ID: 573920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A 56-year-old patient with bronchial asthma and massive psoas muscle hematoma].
    Holler E; Hiller E; Hopfinger C; Meissner H
    Internist (Berl); 1986 Jun; 27(6):400-2. PubMed ID: 3091526
    [No Abstract]   [Full Text] [Related]  

  • 15. [Factor VIII inhibitor-caused hemophilia].
    Peto I; Bánhegyi D; Nemesánszky E; Köves A; Sas G
    Orv Hetil; 1977 Sep; 118(36):2145-9. PubMed ID: 917507
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial plasmapheresis in a haemophiliac with antibodies to FVIII.
    Cobcroft R; Tamagnini G; Dormandy KM
    J Clin Pathol; 1977 Aug; 30(8):763-5. PubMed ID: 599190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of anti-idiotypic antibodies with immune tolerance induction for the treatment of hemophilia A with inhibitors.
    Sakurai Y; Shima M; Tanaka I; Fukuda K; Yoshida K; Yoshioka A
    Haematologica; 2004 Jun; 89(6):696-703. PubMed ID: 15194537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The response to factor VIII infusion in inhibitor patients.
    Allain JP; Verroust F
    Prog Clin Biol Res; 1984; 150():99-108. PubMed ID: 6431445
    [No Abstract]   [Full Text] [Related]  

  • 19. [Comparison of anti-human and anti-porcine factor VIII antibody titers in patients with hemophilia].
    Windyga J; Rzymkiewicz L; Lopaciuk S
    Acta Haematol Pol; 1996; 27(1):27-31. PubMed ID: 8629440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.
    Santagostino E; Gringeri A; Tagliavacca L; Mannucci PM
    Thromb Haemost; 1995 Aug; 74(2):619-21. PubMed ID: 8584995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.